Cross-Seal Closure Device IDE Trial - Study of the Cross-SealTM Suture-Mediated Vascular Closure Device System
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Mazin Foteh, MD
Cardiothoracic and Vascular Surgeons - Austin
Principal Investigator - Prakash Krishnan
Icahan School of Medicine at Mt Sinai
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Vascular Institute of the Rockies
Denver, Colorado, United States
- River City Clinical Research
Jacksonville, Florida, United States
- University of South Florida
Tampa, Florida, United States
- University of Iowa Hospital
Iowa City, Iowa, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Rutgers, the State University of New Jersey
Piscataway, New Jersey, United States
- Mt Sinai Medical Center
New York, New York, United States
- the Trustees of Columbia University in the City of New York
New York, New York, United States
- University of Rochester
Rochester, New York, United States
- Good Samaritan Hospital
Cincinnati, Ohio, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Integris Cardiovascular Physicians
Oklahoma City, Oklahoma, United States
- Lankenau Institute for Medical Research
Wynnewood, Pennsylvania, United States
- North Central Heart
Sioux Falls, South Dakota, United States
- Holston Valley Medical Center
Kingsport, Tennessee, United States
- Cardiothoracic and Vascular Surgeons
Austin, Texas, United States
- St. David'S Heart and Vascular Dba Austin Heart
Austin, Texas, United States
- Texas Heart Institute and Baylor St. Luke'S Medical Center
Houston, Texas, United States
- Sentara Medical Group
Norfolk, Virginia, United States
- Swedish Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Aug 2019
- Primary completion
- 22 Mar 2021
- Completion
- 22 Mar 2021
- Last update posted
- 15 Sept 2025
- Registered enrollment
- 147
- Registry id
- NCT03756558
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.